FDA Clears Multi-Modality Breast Biopsy and Tissue Removal System
The newly cleared system is designed to support breast biopsy procedures across multiple imaging modalities using a single platform.
The newly cleared system is designed to support breast biopsy procedures across multiple imaging modalities using a single platform.
The five-year agreement includes cloud-based imaging modules and AI integration for radiology, breast imaging, and cardiology.
The AI-powered 3D ultrasound is designed to enhance cancer detection in dense breast tissue by providing clearer imaging, faster scanning, and improved diagnostic confidence.
The newly cleared system is designed to support breast biopsy procedures across multiple imaging modalities using a single platform.
Delphinus Medical Technologies has announced that its SoftVue automated breast ultrasound now includes color imaging based on tissue characteristics from the capture of transmission signals.
Read MoreVolpara Solutions has released VolparaDensity 3.0, a breast density assessment tool available for clinical use with digital breast tomosynthesis datasets from multiple manufacturers.
Read More